Ovintiv (NYSE:OVV – Get Free Report) had its price objective increased by research analysts at Scotiabank from $48.00 to $51.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has a “sector outperform” rating on the stock. Scot…